Owing to ongoing tumor progression and significantly elevated NSE levels, we performed a lung biopsy 6 months post resistance to EGFR-TKI therapy, which confirmed a diagnosis of LCNEC. This evidence concerns the gene ENO2 and large cell neuroendocrine carcinoma.